Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Brahmajee Nallamothu

Interventional Cardiology · UMHS

View

Dr. Mohamad Adnan Alkhouli

Interventional Cardiology · Mayo Clinic College of Medicine

View

Dr. Ajay Kirtane

Interventional Cardiology · CUIMC

View

Dr. Manesh Patel

Interventional Cardiology · Duke University

View

Dr. Deepak Bhatt

Interventional Cardiology · Mount Sinai

View

Dr. Sunil Rao

Interventional Cardiology · NYU Langone

View

Dr. Alexander Fanaroff

Interventional Cardiology · UPenn

View

Dr. James Tcheng

Interventional Cardiology · Duke

View

Dr. Pinak Shah

Interventional Cardiology · PHS

View

Dr. Dorairaj Prabhakaran

General Cardiology

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Contemporary Clinical Characteristics, Imaging, Management, and Surgical and Nonsurgical Outcomes of Adult Patients With Subaortic Stenosis.

    Nov 11, 2024DOI: 10.1161/jaha.124.036994Journal ArticleAHA

    Written by: Ankit AgrawalAro Daniela ArockiamMuhammad MajidUshasi SaraswatiJoseph El DahdahSanya ChandnaJoseph KassabMichel Chedid El HelouRishabh KhuranaTiffany DongMustafa AtarElio HarounSamer ZakhourLeonardo RodriguezZoran B PopovicNicholas SmediraBrian P GriffinTom Kai Ming Wang

    Find these authors on Roon

    JK
    Dr. Joseph Kassab
    Interventional Cardiology · UT Southwestern

    METHODS

    The institutional review board approval with waiver of patient informed consent was obtained before the commencement of this retrospective cohort study conducted at the Cleveland Clinic. The data supporting this study's findings are available from the corresponding author upon reasonable request. We identified consecutive patients aged ≥18 years with a diagnosis of both congenital or acquired SAS evaluated at Cleveland Clinic and confirmed on echocardiography between January 2001 and June 2022 from our electronic medical records in Epic (Epic Systems Corporation, Verona, WI) and echocardiography database. Demographics, presentation, past history, medications, laboratory investigations, cardiac imaging, procedural details, and in‐hospital and postdischarge clinical outcomes were collected from the time of the first medical visit to the last medical contact or June 2023. Patients were divided into 2 main groups: those who received medical management only for SAS (who never underwent any surgery for SAS at any point) and those who underwent surgical intervention before presentation to our institution or during follow‐up. At our institution, we use a very standard approach for surgical intervention for SAS. Classical membranes are a ring of scar that resides on the mid portion of the anterior mitral leaflet, both the fibrous trigones, below the membranous septum, and then onto the septum. In most cases, this fibrous ring can be carefully dissected from the underlying structures. Additionally, because the majority of patients with subaortic membranes have a narrow LVOT, a myectomy is typically performed, removing as much septal muscle as safely possible.Each type of cardiac imaging was performed at the discretion of managing clinicians. Philips (Philips Medical Systems, Bothell, WA, USA) and GE (GE Medical, Milwaukee, WI, USA) scanners were used for transthoracic echocardiography performed in all patients, and both were also used for transesophageal echocardiography and exercise stress echocardiography performed in selected patients respectively. Cardiac computed tomography was performed using Siemens Somatom Force or Definition Flash scanners in selected patients with iodinated contrast and ECG‐gating. Cardiac magnetic resonance was performed using Philips Achieva 1.5 Tesla or Ingenia 3.0 Tesla scanners in selected patients. Figure 1 illustrates examples of multimodality cardiac imaging evaluation of SAS.A, Transthoracic echocardiogram: parasternal long‐axis view showing subaortic membrane (white arrow in the left panel), with color Doppler showing flow acceleration (white arrow in the mid panel), and with continuous wave Doppler indicating peak left ventricular outflow tract velocity 3.02 m/s and gradient 36 mm Hg (white arrow in the right panel). B, Transesophageal echocardiogram evaluation: midesophageal long‐axis views showing subaortic membrane (white arrow in the left panel), with color Doppler showing flow acceleration (white arrow in the mid panel), and after resection surgery with no residual subaortic membrane (white arrow in the right panel). C, Cardiac computed tomography retrospective‐gated 4‐dimensional imaging with contrast: reconstructed oblique left ventricular outflow tract to aortic root view showing subaortic membrane (white arrow in the left panel), and reconstructed short axis view of subaortic membrane and stenosis (white arrow in the right panel). D, Cardiac magnetic resonance imaging steady‐state free precession sequence showing left ventricular outflow tract view showing subaortic membrane (white arrow in the left panel), and outflow tract to aorta flow acceleration from the subaortic membrane in systole (white arrow in the right panel).The primary composite outcome was death or heart failure readmission during follow‐up. The secondary composite outcome was SAS recurrence and redo surgery combined during follow‐up. Other secondary outcomes include the constituents of the composite outcomes, along with myocardial infarction and stroke. The follow‐up duration is the time between the first point of cardiology contact at our center until either their death or most recent medical contact as of June 2023.Patients who underwent medical management were compared with the patients who underwent surgery for SAS, either before presentation or during follow‐up. Categorical variables were reported as frequency (percentage), and the Fisher exact or chi‐square test was used to compare them in univariable analyses. Continuous variables were reported as mean±SD compared in univariable analyses using the Student t test. A 2‐sided P value of <0.05 is considered significant. Kaplan–Meier survival curves were used to illustrate outcomes and compared using an univariable log‐rank test. Multivariable analyses for the composite primary and composite secondary end points were performed using Cox proportional hazards regression to present hazard ratios (HRs) with their 95% CIs, using prespecified covariates of age, sex, body mass index, New York Heart Association (NYHA) class, estimated glomerular filtration rate, left ventricular ejection fraction, peak LVOT gradient, and medical management. We tested the proportional hazards assumption using the Schoenfield residual test in our cohort, which confirmed proportionality and no violation of this assumption. All statistical analyses were conducted using Microsoft Excel and IBM SPSS Statistics, version 28 (IBM Corp., Armonk, NY).

    RESULTS

    The study cohort consisted of 235 patients who underwent surgery (129 in the past, 106 during follow‐up) and 249 who received medical management for subaortic stenosis. The baseline characteristics of the overall surgical and medical management cohorts are presented in Table 1. The mean age was 55.8±17.1 years, 67.5% were female, and SAS causes were deemed 51.2% congenital and 48.7% acquired. The most commonly associated cardiac conditions were aortic valve regurgitation and stenosis in 21%/18.8%, hypertrophic cardiomyopathy in 14.4%, bicuspid aortic valve in 13%, and ventricular septal defect in 10.3%. Prior cardiac surgery at 56.6% and hypertension at 43.5% were highly prevalent. There were no statistically significant differences in demographic, clinical, laboratory, and medication parameters between patients with SAS medically or surgically managed.Clinical Characteristics of Patients With Subaortic StenosisLV indicates left ventricular; and LVOT, left ventricular outflow tract.Asian, including East Asian, Indian and Middle Eastern.Transthoracic echocardiography was used in all patients, and based on this, the overall mean left ventricular ejection fraction was 60.2%±14.0%, LVOT peak and mean gradients and peak velocity of 57±40 mm Hg, 32±22 mm Hg, and 352±140 cm/s, with no differences between surgically and medically managed patients. Other imaging modalities include 27.8% transesophageal echocardiography, 25.6% stress echocardiography, 21.6% computed tomography, and 30.9% cardiac magnetic resonance.Among 484 patients with SAS during a mean follow‐up of 7.0±6.5 years, there were 56 (11.5%) deaths, 33 (6.8%) had heart failure hospitalization, 1 (0.2%) had a stroke, and 2 (0.4%) had a myocardial infarction. Of the 235 surgically managed patients, there were 27 (11.4%) deaths (including 1 (0.9%) operative mortality among the 106 patients who had surgery during follow‐up), 39 (16.5%) had SAS recurrence, and 14 (5.9%) had redo SAS surgery. Kaplan–Meier survival curves are presented in Figure 2 for the main outcomes of the study. One‐, 5‐, and 10‐year survival rates were 97.8%, 92.6%, and 87.9% overall, 98.1%, 91.9%, and 90.8% in the surgically managed, and 97.3%, 93.4%, and 84.8% in the medically managed subgroups (log‐rank P=0.542).M indicates medical management; S, surgical management; and SAS, subaortic stenosis. Kaplan‐Meier survival analyses for primary outcomes of all‐cause mortality (A), heart failure hospitalization (B), and secondary outcomes of recurrent subaortic stenosis and redo surgery (C).For the multivariable model of the primary composite end point of all‐cause mortality and heart failure hospitalizations during follow‐up, older age per 10 years (HR, 1.37 [95% CI, 1.12–1.68]) and baseline NYHA class (HR, 2.18 [95% CI, 1.43–3.31]) are statistically significantly associated with this outcome (Table 2). On the other hand, higher NYHA class on presentation (HR, 6.88 [95% CI, 1.68–22.15], P=0.007), higher body mass index (HR, 1.22 [95% CI, 1.00–1.50], P=0.043), and higher peak LVOT gradient (HR, 1.34 [95% CI, 1.04–1.79], P=0.034) were statistically significantly associated with the secondary composite end point of SAS recurrence or redo surgery during follow‐up in multivariable analysis (Table 3).Multivariable Analysis for Factors Associated With the Primary End Point of All‐Cause Death and Heart Failure HospitalizationsP‐value is statistically significant (<0.05).Multivariable Analysis for Factors Associated With Subaortic Stenosis Recurrence and Redo Surgery Following Prior Subaortic Stenosis SurgeryP‐value is statistically significant (<0.05).

    DISCUSSION

    This single‐center cohort study reviewed one of the largest adult cohorts with SAS in the literature with some important findings. A significant minority of patients with SAS are associated with other heart conditions, including aortic valve disease and hypertrophic cardiomyopathy but also prior cardiac surgery and cardiovascular risk factors. Almost half of patients with SAS underwent surgery, whether in the past or during follow‐up for SAS. Despite this, mortality and morbidity events occurred in up to 1 in 8 patients during follow‐up, and key adverse prognosticators were identified.Similar to prior literature, we report a slight female predominance in adults with SAS and frequent association with other congenital and acquired heart diseases, including aortic valve stenosis or regurgitation, bicuspid aortic valve, hypertrophic cardiomyopathy, ventricular septal defect, and aortic coarctation.6, 11, 12, 13, 14, 15 Furthermore, the fact that just over half of our cohort with SAS had prior cardiac surgery signals that SAS is not only associated with other heart conditions that warrant cardiac surgery but that they can persist or develop after cardiac surgery. Advances in cardiac surgery techniques also mean that people with SAS, diagnosed whether in childhood or adulthood and whether in isolation or with other congenital or acquired heart conditions, are able to live longer and have better outcomes into adulthood. Transthoracic echocardiography remains the first‐line imaging modality to diagnose subaortic membrane in terms of both anatomic depiction and functional assessment of LVOT obstruction, along with assessing cardiac chamber size and function, along with concomitant valvular or other congenital heart disease.2 However, supplementary multimodality cardiac imaging is sometimes necessary for evaluation, including transesophageal echocardiography, computed tomography, or cardiac magnetic resonance with a superior spatial resolution to delineate the anatomical location and extent of SAS and exercise stress echocardiography to assess hemodynamic response to exercise.2Our study reported 0.9% operative mortality for SAS surgery performed at our center during follow‐up and 1‐, 5‐, and 10‐year survival of 97.8%, 92.6%, and 87.9% during follow‐up for the SAS cohort. This compares to 0% to 4% operative mortality for SAS surgery in the literature and a pooled 0.22% per year % mortality during follow‐up.10, 16, 17, 18, 19, 20, 21 The low operative mortality partly reflects patients with SAS being, on average, younger with a lower prevalence of comorbidities than other cardiac surgeries.22 However, it also highlights that adverse in‐hospital events are rare when SAS surgery is performed at tertiary centers specialized in cardiac surgery like ours. SAS is occasionally diagnosed intraoperatively, especially for the aortic valve, hypertrophic cardiomyopathy, and congenital heart disease surgeries, given their associations, so cardiac surgeons need to be familiar with its surgical resection techniques to be able to call upon this skill whenever it is encountered. Careful attention should also be paid when managing patients with SAS who have adverse prognosticators found in our study, including higher age and NYHA class, which reflect worse heart disease and failure status, and those identified in other studies such as mitral stenosis and Shone's complex.14, 16 Treatment strategies may include optimizing medical therapy for heart failure symptoms, close echocardiography surveillance, and earlier referral for surgery, warranting further research.2, 23Another important adverse outcome following patients with SAS who undergo surgery is the recurrence of SAS and redo operations, which was not infrequent at 9.0% and 3.6% of our surgical cohort during 7 years of follow‐up, compared with recurrent SAS as substantial as 55% and 6% to 30% redo surgeries in the literature.24, 25 We identified the higher body mass index, baseline NYHA class, and peak LVOT gradient to be statistically significantly associated with these outcomes. Key predictors of SAS recurrence and redo operations reported in other studies include higher preoperative LVOT peak gradient similar to our study, along with younger age, other left‐sided heart lesions, and anatomically shorter distance of subaortic membrane to aortic valve and peeling of membrane from the mitral valve.3, 8 The pathophysiology of SAS recurrence is not well understood, but possibilities include tissue regrowth in the area of the septum, starting from the initial fibromuscular obstruction.26 An alternative theory suggests that scarring occurs in the subvalvular region during the healing process, consequently stabilizing the size of the LVOT.27 Because of these incidences of SAS recurrence, careful routine long‐term clinical and imaging surveillance to enable prompt medical and surgical treatments is necessary for the management of these patients, especially if predictors of recurrence are present.1, 2 Table 4 presents a few previously established studies depicting the predictors of mortality and redo surgery.14, 16, 20, 24, 28, 29Subaortic Stenosis Studies Showing Predictors of Mortality and Redo SurgeryLVOT indicates left ventricular outflow tract.As per the 2018 American College of Cardiology/American Heart Association Guideline for the Management of Adults with Congenital Heart Disease, surgical intervention for patients with SAS is recommended when the maximum gradient is ≥50 mm Hg and symptoms are related to SAS (Class I recommendation).1 Additionally, patients with SAS and maximum gradient <50 mm Hg and heart failure or ischemic symptoms or left ventricular dysfunction related to SAS are considered for surgery as well (Class I recommendation).1 Higher peak gradients, in fact, were the primary indication for index and redo‐surgery in the majority of the cases in our cohort study. On follow‐up, if the patients remained asymptomatic without severe SAS or there was no progressive worsening of LVOT gradients, they were managed medically.This study has some limitations. It is a single‐center retrospective cohort study with intrinsic biases. Many patients were diagnosed, and some had surgery outside our hospital, so patients reviewed at index clinical encounters with us were at heterogeneous stages in the natural history of SAS. Allocation bias could arise from the systematic differences in how the patients were assigned to medical management or surgical intervention. The sample size is moderate, albeit being one of the largest cohorts with SAS in the literature, but this means some outcomes had low event rates, and not all predictors could be identified in multivariable analyses. Cardiac imaging other than transthoracic echocardiography was inconsistently performed across the cohort. The follow‐up duration was variable and relatively short given that this was a contemporary cohort, and many patients lived in different states or even countries. Other outcomes we were unable to collect to analyze include symptoms and quality of life.

    CONCLUSIONS

    SAS is a relatively rare condition in adults and is associated with aortic valve, other congenital heart lesions, cardiovascular risk factors, and prior cardiac surgery in a proportion of patients. Almost half of patients with SAS underwent surgery in the past or during follow‐up; however, 11% to 12% of patients died during the follow‐up period. Increasing age and baseline NYHA class are key predictors of adverse outcomes, and further research is necessary to determine the optimal management strategy to improve outcomes in patients with SAS.

    Sources of Funding

    None.

    Disclosures

    None.
    JK

    Dr. Joseph Kassab

    Cardiology · Interventional Cardiology
    The University of Texas Southwestern Medical Center
    josephk